Adverse Drug Event, Medication Errors and Other Product Use Errors and Issues
Conditions
Keywords
Computerized Provider Order entry, Patient safety, Quality improvement, Medication errors, Adverse events, Bar code medication administration, Neonates
Brief summary
This is a monocentric prospective pre and post-intervention study, aiming at analyzing the efficacy of the Computerized Provider Order Entry (CPOE) plus Bar Code Medication Administration (BCMA) as compared to paper order entry in reducing medication erros (MEs) in the Neonatal Intensive Care Unit (NICU)
Detailed description
Medication errors are a burden to the health care system. The neonatal population, in particular the infants admitted to the NICU, are at higher risk of MEs as compared to the adult and pediatric population. Moreover adverse events (ADEs) occur more frequently and may be particularly severe in neonates. Several strategies have been tried in order to decrease the incidence of MEs in the NICU. Among these, some studies investigated the effectiveness of CPOE in reducing MEs in hospitalised patients. However, results have been inconsistent. So far, no study investigated the association of CPOE + BCMA in neonates. The investigators designed a monocentric prospective pre and post-intervention observational study to investigate the efficacy of the CPOE plus BCMA as compared to paper order entry in reducing MEs in the NICU population.
Interventions
Computerized provider order entry (CPOE) refers to the process of providers entering and sending treatment instructions - including medication, laboratory, and radiology orders - via a computer application rather than paper, fax, or telephone. The bar Code Medication Administration (BCMA) is a system that consists of a bar code reader, a portable or desktop computer with wireless connection, a computer server, and some software. Before the administration of medications to the patients the patient unique barcode identification is scanned in order to verify the patient's identity.
Sponsors
Study design
Eligibility
Inclusion criteria
* Admission to the NICU * Need of pharmacological intervention * Informed parental consent
Exclusion criteria
* Lack of parental consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of medication errors | From date of NICU admission up to discharge, up to 18 months | The investigators will record all types of errors (prescription, transcription, preparation, administration errors) through spontaneous reporting, structured daily audit and chart revision |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of preventable adverse drug events | From date of NICU admission up to discharge, up to 18 months | The investigators will record the number of preventable and non preventable adverse drug events |
Countries
Italy